Table 1 Baseline characteristics
Group A (n = 110) | Group B (n = 110) | |
|---|---|---|
Age | 61.4 (13) | 60.8 (12.7) |
Male no. (%) | 51 (46.4%) | 45 (40.9%) |
Weight (kg) | 76.7 (12) | 74 (10.7) |
Not SARS-CoV-2 vaccinated | 105 (98.1%) | 107 (98.2%) |
Critical cases on admission | 21 (19.1%) | 20 (18.2%) |
WHO score on admission | 5 (5–6) | 5 (5–6) |
Smokers | 16 (14.5%) | 13 (11.8%) |
CLD | 8 (7.4%) | 7 (6.5%) |
Hypertension | 50 (45.9%) | 46 (41.8%) |
Cardiac disease | 14 (13%) | 13 (11.8%) |
Diabetes mellitus | 46 (42.6%) | 39 (35.8%) |
ESLD | 9 (8.5%) | 10 (9.1%) |
ESRD | 2 (1.8%) | 1 (0.9%) |
Neurological disease | 6 (5.6%) | 5 (4.6%) |
Basal GCS | 15 (15–15) | 15 (15–15) |
Basal SOFA | 2 (1–3) | 2 (1–3) |
AST (U/L) | 40 (25.25–59.5) | 36 (25.5– 51.5) |
ALT (U/L) | 33 (18–61.75) | 31 (17–52) |
Total Bilirubin (mg/dL) | 0.54 (0.33–78) | 0.46 (0.36–0.7) |
INR | 1.1 (1.01–1.22) | 1.13 (1.03 –1.22) |
Albumin (g/dL) | 3.2 (2.9–3.5) | 3.1 (2.9–3.5) |
S.Cr (mg/dL) | 0.96 (0.8–1.25) | 0.9 (0.7–1.27) |
CK (IU/L) | 75 (40–187.5) | 61 (36–163.5) |
Hemoglobin (g/dL) | 12.8 (11.54–13.9) | 12.48 (11.17–13.83) |
TLC (103/µL) | 7.9 (5.79–9.97) | 8.93 (5.94–12.68) |
Lymph (103/µL) | 0.83 (0.52–1.14) | 0.92 (0.59–1.51) |
Platelets (103/µL) | 197.5 (135.5–265.55) | 211.5 (149.75–284) |
LDH (IU/L) | 311.5 (254–407.75) | 369 (252.25–509.5) |
D-dimer (g/L) | 0.2 (0–0.3) | 0.2 (0–0.4) |
CRP (mg/L) | 96 (44–143) | 96 (27–129) |
Ferritin (µg/L) | 514.5 (315.5–543.5) | 529 (370–546) |